Eden Research PLC has received authorization in Portugal for its first product, Mevalone (previously referred to as “3AEY”). The Portuguese authorities have issued “Authorisation for Sale” number 1012 covering the use of Mevalone for the control of botrytis (grey mould) on grapes. Mevalone will be marketed in Portugal by Eden’s partner, K. & N. Efthymiadis S.A.
Mevalone 是一种基于萜烯的杀菌剂，主要针对灰霉病，这是一种广泛传播的真菌病，会导致许多水果和蔬菜出现灰霉病，从而导致具有商业价值的作物迅速损失。
该批准对 Eden 来说是一个重要的里程碑，并使公司能够接触到另一家欧洲顶级葡萄生产商。 Mevalone 在不同国家以不同的商品名称销售，已在多个国家获得批准，包括西班牙、意大利、肯尼亚、马耳他、希腊、保加利亚，最近还包括法国。此外，Mevalone 已经在其中许多市场取得了巨大的商业成功。
Sean Smith, Chief Executive Officer of Eden, commented: “We are delighted to announce that we have gained authorisation for the sale and use of Mevalone in Portugal, further-increasing Eden’s geographic footprint. Together with Italy, France and Spain we now operate in the four largest grape producing countries in Europe, and we continue to expand into additional countries worldwide.
“Botrytis has the potential to destroy up to 30% of a vineyard in a matter of days. Consequently Mevalone plays a very important role in the treatment of this disease. This approval from the Portuguese authorities opens up significant opportunities for additional crops in Portugal through minor and/or emergency use label extensions. Italy recently received emergency authorisation for the use of Mevalone on pomegranate, and we expect to realise further extensions in many current and new territories.
“Today’s announcement is an important commercial opportunity for Eden and we are pleased to be working with our partner, K. & N. Efthymiadis S.A., to develop the Company’s presence in Portugal. In addition, it is a positive indicator of the regulatory progress Eden is making and we look forward to further approvals in due course.”
Eden 将报告截至 2017 年 9 月 29 日的六个月的中期业绩。